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Regional cerebral blood flow in dialysis encephalopathy and primary
degenerative dementia. Regional cerebral blood flow (CBF) was mea-
sured in patients with dialysis encephalopathy, primary degenerative
dementia, dialysis patients with no central nervous system (CNS)
complications, and normal controls. Both groups of dialysis patients
(with and without CNS complications) demonstrated higher CBF val-
ues, and the dementia patients, lower CBF values than the controls.
The dialysis patients had lower hematocrit, which correlated inversely
with the cerebral blood flow. No such correlations were present in
normals and patients with primary degenerative dementia. The dialysis
patients and controls obtained similar CBF when the flow values were
adjusted for the differences in hematocrit.
Debit sanguin cérébral regional lors de l'encéphalopathie dialytique et
de Ia démence degenerative primitive. Le debit sanguin cérébral regional
(CRF) a ete mesurC chez des malades atteints d'encéphalopathie
dialytique, de démence degenerative primitive, chez des dialyses sans
complications CNS et chez des contrbles normaux. Les deux groupes
de dialyses (avec et sans complications CNS) ont présenté des valeurs
de CRF plus ëlevées, et les malades ddments, des valeurs plus faibles de
CRF par rapport aux contrôles. Les dialyses avaient un hématocrite
plus bas qui Ctait inversement corrélé au debit sanguin cérdbral. Ces
correlations n'existaient pas chez les normaux ni chez les malades
atteints de démence degenerative primitive. Les dialyses et les
contrbles avaient des CRF identiques lorsque les valeurs de debit
Ctaient ajustées en fonction des differences d'hématocrite.
Various psychiatric and neurologic symptoms have been
reported in patients with chronic renal failure on renal dialysis
[1, 2]. Dialysis encephalopathy is a central nervous system
syndrome characterized by speech disturbances, multifocal
myoclonus, neuropsychiatric manifestations,and electroenceph-
alographic changes. Usually it is associated with rapid deterio-
ration and death within one month to one and one-half years [3].
Little is known about the brain pathophysiology associated with
dialysis encephalopathy. Investigations carried out with cere-
brospinal fluid analysis, radionuclide brain scans, pneumoen-
cephalograms, and computed tomography scans most often
have yielded negative results [3, 4]. Postmortem neuropatho-
logic findings often are normal or non-specific [4]. More re-
cently, neurofibrillary tangles with a distribution pattern similar
to Alzheimer's disease have been reported in this condition 151.
Received for publication September 4, 1984,
and in revised form January 2, 1985
© 1985 by the International Society of Nephrology
Aluminum intoxication has been postulated to play a causal role
in both dialysis encephalopathy [6] and Alzheimer's disease [7].
Dementias often are associated with reductions in cerebral
capillary perfusion [8, 9]. The intensity of dementias, quantified
with neuropsychological test batteries and with postmortem
examinations, has been found to correlate with changes in
cerebral blood flow (CBF) [10]. Regional CBF also has been
claimed to be useful in differentiating various subtypes of
dementias [101. No information is available on the regional
cerebral blood flow changes associated with dialysis encepha-
lopathy.
Methods
Regional cerebral blood flow measurements were obtained
from groups of subjects with dialysis encephalopathy, dialysis
patients without any central nervous system dysfunction, pa-
tients with primary degenerative dementia, and normal controls
(age in years: 53, sD6; 57, sD4; 70, sD9; and 63, sD8, respec-
tively). There were six male participants in each group. The
criteria used for making the diagnosis of dialysis encephalopa-
thy are given in Table 1. Primary degenerative dementia was
diagnosed with the criteria given in the Diagnostic and Statis-
tical Manual of the American Psychiatric Association [11]. This
category includes dementias of insidious onset and gradually
progressive course for which all other specific causes have been
excluded. The term primary degenerative dementia is preferred
over more specific diagnosis such as Alzheimer's disease,
which is based largely on postmortem histopathological find-
ings. Absence of neurologic symptoms in the second group of
dialysis patients was confirmed by a nephrologist and a psychi-
atrist and in the normal controls by a psychiatrist, Hematocrit,
which is known to influence CBF, was measured in all subjects
prior to the CBF measurements.
Cerebral blood flow measurements were conducted with the
'33Xenon inhalation technique [12]. '33Xenon is an inert, radio-
active gas which is colorless, odorless, and tasteless. A mixture
of the isotope with room air was administered through a
close-fitting face mask for 1 mm. The gas reaches the brain via
the bloodstream from which it diffuses into the brain paren-
chyma. The rates of clearance of the isotope from different
brain regions, which parallel the corresponding perfusion rates,
were traced by a system of 32 suitably collimated scintillation
detectors mounted on a helmet and applied to the scalp. CBF
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Table 1. Criteria for the diagnosis of dialysis encephalopathy
Initial presenting symptoms Later symptoms
Patient 1 Episodic memory loss Myoclonic jerks
Periods of confusion Speech difficulty
Abnormal EEG
Diagnosis: September, 1983 Dementia
CBF: October, 1983 EEG markedly abnormal
Mutism
Died: September, 1984
Patient 2 Stuttering
Word searching
Isolated jerking of legs
Marked short-term memory
loss
Poor concentration
Loss of intellectual skills
Abnormal EEG
Diagnosis: February, 1984
CBF: March, 1984 Died: October, 1984
Patient 3 Cramping of calf muscles
Muscle twitches
Dysarthria
Anarthria
Diagnosis: April, 1983
CBF: November, 1983
Abnormal EEG
Mild dementia
Poor short-term memory
Judgment impaired
June, 1984: Doing well on
Desferal
Patient 4 Sudden onset of severe
stuttering
Diagnosis: November, 1979
CBF: October, 1983
Myoclonic jerks
Mild intellectual
impairment
Mild short-term memory
loss
Abnormal EEG
November, 1984: Greatly
improved and only mild
speech difficulty remains
Patient 5 Speech difficulty
Jerky movements of arms
Forgetfulness
Diagnosis: August, 1983
CBF: October, 1983
Abnormal EEG
Dementia
Short-term memory loss
Intellectual deterioration
November, 1984: Doing
well on Desferal
Patient 6 Clumsiness of the hands
Myoclonic jerks
Grand mal seizure
Bizarre, inappropriate
behavior
Diagnosis: August, 1983
CBF: September, 1983
Slowing and slurring of
speech
Severe memory loss
Insight and judgment poor
Abnormal EEG
November, 1984: Doing
poorly
was calculated from these clearance curves using a bicompar-
tmental model with an on-line computer. Differences in the
relative solubility of Xenon in blood and brain tissue were
corrected for using predetermined blood/brain partition coeffi-
cients. Gray matter perfusion rates (computed from the fast-
clearing first compartment) expressed as ml/l00 g/min were
utilized as the CBF index in the present study. The reliability
and validity of this cerebral blood flow measurement technique
in normal and abnormal subject populations are very well
established [12—14], and it has been used extensively in
dementia research [8, 10].
All CBF measurements were performed in a quiet, semi-dark
room with eyes open. The same equipment and laboratory were
used for all measurements. Subjects were allowed sufficient
time to acclimate to the laboratory and face mask so that true
resting flow values were obtained. Blood pressure, pulse rate
and end-tidal levels of carbon dioxide (PECO2) were monitored
Table 2. Dialysis and its relationship to the CBF measurements
Dialysis
encephalopathy Controls
Time since beginning
dialysis, months 95.3 (44—144) 102 (39—147)
Time since diagnosis of
dialysis encephalopa-
thy, months 85.2 (43—142) —
Hemodialysis, hours
per week 11.5 (9—12) 11.9 (10.5—12)
Delivery system DW*_4, CC+—2 DW54, CC—2
Dialyzer GM—5, CPPD0_l GM—3, CPPD0_3
Symbols for brand names are: ', Drake-Willock; , Cobe Centry;,
Gambro Lundia Major; 0, Cobe Parallel Plate.
during the procedure. A single-channel EEG was utilized to
detect and prevent sleep onset. All patients in the control and
dialysis dementia groups were receiving home hemodialysis and
the CBF measurements were performed on the days between
dialysis (see Table 2). There were no significant differences
between the two groups at the time of cerebral flow measure-
ment relating to the serum values for sodium, potassium,
chloride, carbon dioxide content, calcium, urea, and creatinine.
The mean serum phosphorus in the dialysis encephalopathy
group was 6.7 mg/dl (SD 1.07) and in the dialysis patients
without CNS complications 4.6 mg/dl (SD 1.84). The difference
was statistically significant at the 0.05 level. This can be
explained by the fact that patients with dialysis dementias were
not receiving aluminum-containing phosphate binders, but less
efficient phosphate binders, magnesium hydroxide and calcium
carbonate.
Results
Tables 3 and 4 show the regional cerebral blood flow values of
the left and right hemispheres, respectively, and Figure 1, the
locations of various scintillation detectors. First, the four
groups were compared on resting CBF values, PECO2 levels,
blood pressure, and hematocrit (Tables 3, 4, 5) via analysis of
variance and post-hoc Newman Keuls. The four groups showed
no significant differences on PECO2 levels. Both groups of
dialysis patients showed significantly higher flow values (P <
0.05) and patients with primary degenerative dementia lower
values (P < 0.05) than the normal controls. Dialysis patients
with and without encephalopathy obtained similar CBF values.
Several investigators have reported an age-related decrease in
cerebral blood flow [14]. Patients with primary degenerative
dementia were significantly older than the other three groups
who did not differ significantly in age (analysis of variance).
Analysis of covariance was carried out with age as the covariate
and similar results were obtained (Figure 2). Next, correlations
between hematocrit and the mean CBF values were calculated.
The two variables showed significant inverse correlations in
patients with dialysis encephalopathy [r = — 0.80, P < 0.01]
and dialysis patients without central nervous system complica-
tions [r =
—0.77, P < 0.05]. However, they did not correlate
significantly in normals and in patients with primary degenera-
tive dementia. Next, the two groups of dialysis patients were
compared with the normal controls using analysis of covariance
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Table 3. Comparisons between the four groups on CBF via analysis of variance (left hemisphere)
Primary
Brain Region
Dialysis
encephalopathy
Uncomplicated
dialysis
degenerative
dementia
Normal
control F-ratio P
Left Fl 78 SD 13 79 SD 7 54 SD 6 63 SD 7 9.99 <.001
F2 72 SD 16 79 SD 8 50 SD 11 63 SD 7 6.82 <.003
F3 83 SD 15 77 SD 13 52 SD 7 65 SD 6 7.92 <.001
F4 83 SD 19 82 SD 5 59 SD 3 68 SD 6 6.46 <.003
F5 75 SD 18 76 SD 11 50 SD 5 59 SD 6 6.17 <.004
Cl 75 SD 14 84 SD 9 58 SD 8 66 SD 9 6.21 <.004
C2 78 SD 16 76 SD 9 52 SD 4 64 SD 8 6.79 <.003
TI 77 SD 15 72 SD 8 55 SD 8 63 SD 12 3.71 <.03
T2 72 SD 16 74 SD 11 48 SD 8 60 SD 5 5.90 <.005
T3 76 SD 22 73 SD 13 46 SD 4 55 SD 3 6.16 <.004
P1 74 SD 18 75 SD 8 43 SD 6 62 SD 7 8.89 <.001
P2 72 SD 18 72 SD 10 47 SD 8 61 SD 6 5.79 <.005
P3 71 SD 16 74 SD 8 44 SD 7 58 SD 6 9.44 <.001
P4 71 SD 18 76 SD 12 43 SD 4 59 SD 7 8.18 <.001
01 70 SD 15 74 SD 14 44 SD 10 60 SD 3 6.96 <.002
02 76 SD 14 75 SD 12 51 SD 8 63 SD 8 6.24 <.004
Gray matter perfusion expressed as ml/100 glmin. On post-hoc analysis, both dialysis groups had significantly (P <0.05) higher and patients with
primary degenerative dementia, significantly lower (P < 0.05) flow values in all regions than the controls. The two dialysis groups did not differ
significantly on CBF.
Table 4. Comparisons between the four groups on CBF via analysis of variance (right hemisphere)
Primary
Brain Region
Dialysis
encephalopathy
Uncomplicated
dialysis
degenerative
dementia
Normal
control F-ratio P
Right Fl 81 SD 18 78 SD 7 62 SD 9 64 SD 9 3.51 <.04
F2 79 SD 22 80 SD 11 55 SD 8 64 SD 8 4.50 <.02
F3 79 SD 19 77 SD 12 52 SD 9 65 SD 9 4.50 <.02
F4 76 SD 19 77 SD 12 55 SD 6 64 SD 5 10.08 <.001
F5 77 SD 17 77 SD 11 60 SD 9 58 SD 7 4.07 <.03
Cl 77 SD 18 78SD 9 59SD4 62 SD II 3.61 <.04
C2 81 SD 16 80 SD 11 58 SD 6 63 SD 4 6.04 <.005
TI 78 SD 12 74 SD 10 59 SD 5 60 SD 7 5.70 <.006
T2 73 SD 17 73 SD 13 50 SD 7 63 SD 8 4.34 <.02
T3 67 SD 15 70 SD 12 46 SD 6 59 SD 11 4.41 <.02
P1 70 SD 17 74 SD 13 47 SD 6 59 SD 5 5.32 <.008
P2 73 SD 13 72 SD 8 46 SD 3 62 SD 3 11.78 <.001
P3 75 SD 17 77 SD 11 48 SD 6 61 SD 4 8.13 <.001
P4 70 SD 15 81 SD 11 47 SD 7 59 SD 7 9.84 <.001
01 74 SD 18 75 SD 10 44 SD 9 57 SD 6 7.64 <.002
02 72 SD 14 77 SD 8 56 SD 9 65 SD 5 4.65 <.02
Gray matter perfusion expressed as ml/100 glmin. On post-hoc analysis, both dialysis groups had significantly (P < 0.05) higher and patients with
primary degenerative dementia, significantly lower (P < 0.05) flow values in all regions than the controls. The two dialysis groups did not differ
significantly on CBF.
with hematocrit as the covariate. The CBF differences between
the three groups of subjects disappeared.
Discussion
Results of the present study indicate that dialysis encepha-
lopathy, unlike primary degenerative dementia, is associated
with increased cerebral blood flow. This cerebral hyperperfu-
sion, which was seen also in dialysis patients without CNS
complications, correlated with lower hematocrit values. Cere-
bral blood flow values normalized when the effects of hemato-
crit were covaried out. Patients on dialysis, with and without
central nervous system pathology, did not differ significantly on
CBF or hematocrit. These findings were unrelated to age since
controlling for the effects of age did not alter the results. Carbon
dioxide is well known for its powerful vasodilatory action [15].
However, the four groups did not differ on end-tidal carbon
dioxide, and resting cerebral blood flow is influenced only
minimally by CO7 levels.
Cerebral blood flow is reduced in most conditions associated
with brain atrophy [10] and, therefore, the findings of the
present study argue against gross brain degeneration in dialysis
encephalopathy. This is consistent with the results of most
postmortem studies [4]. In the normal brain, function, cerebral
blood flow, and cerebral metabolism are interrelated closely.
Reduction in brain activity associated with sleep, drug-induced
narcosis, and toxic encephalopathies [10, 14] is characterized
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Table 5. Comparison between the four groups on relevant physiological variables
Primary
Variable
Dialysis
encephalopathy
Uncomplicated
dialysis
degenerative
dementia
Normal
controls F-ratio P
PECO2a 33.5 SD 4 33.0 SD 2 32.8 SD 5 38.4 SD 5 1.47 NS
Systolic BP 120.0 SD 16 147.2 SD 23 128.5 SD 20 120.0 SD 16 1.00 NS
Diastolic BP 68.0 SD 20 65.7 SD 5 65.7 SD 5 76.5 SD 9 1.00 NS
Hematocrit 29.9 SD 6 27.3 SD 10 43.9 SD 4 44.4 SD 3 10.28 <.001
a mm of mercury.
by modest CBF decreases. The 133Xenon inhalation technique
measures cortical perfusion primarily [12, 14]. The absence of
CBF reduction in dialysis encephalopathy suggests that this
condition may not be associated with significant changes in
cortical activity. However, the validity of such a conclusion is
weakened considerably by the relatively small number of
participants in the present study and by the confounding effect
of hematocrit on cerebral blood flow in the dialysis patients.
Dialysis encephalopathy patients showed much larger varia-
tions in both CBF and hematocrit. The study demonstrated
substantial differences in the cerebral blood flow patterns
associated with dialysis encephalopathy and primary degener-
ative dementia. Consistent decreases in capillary perfusion to
almost all brain regions were seen in the latter group. Thus,
these findings do not lend support to hypotheses based on
similarities in the neuropathology of two conditions.
The inverse correlations between hematocrit and CBF in the
dialysis patients merit special attention. Increases and de-
creases in hematocrit are associated with cerebral hypo- and
hyperperfusions, respectively [16, 17]. Hyperdynamic blood
circulation, possibly related to lower hematocrit, has been
described in dialysis patients [18]. Since blood is the vehicle
through which various substances reach the central nervous
system, cerebral hyperperfusion might be associated with in-
creases in the effects of drugs and toxins on the brain. Dialysis
Fig. 2. Hemispheric gray matter perfusion in the four groups of
subjects. Symbols are: , right hemisphere; , left hemisphere. Anal-
ysis ofcovariance with age as the covariate: right hemisphere, F = 3.73,
P < 0.03, left hemisphere, F = 4.76, P < 0.02.
has been associated with a host of such drug-induced central
nervous system symptoms as confusional states, deliria, and
convulsions [19]. In addition, it might facilitate also the delivery
of toxic substances such as aluminum to the brain. Aluminum
intoxication is believed by many to play a causal role in dialysis
encephalopathy [5, 6].
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